These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3488702)

  • 1. Methylene blue decreases the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage.
    Richter AM; Abboud RT; Johal SS
    Am Rev Respir Dis; 1986 Aug; 134(2):326-7. PubMed ID: 3488702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects.
    Mohsenin V; Gee JB
    Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.
    Cochrane CG; Spragg R; Revak SD
    J Clin Invest; 1983 Mar; 71(3):754-61. PubMed ID: 6600748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid.
    Abboud RT; Fera T; Richter A; Tabona MZ; Johal S
    Am Rev Respir Dis; 1985 Jan; 131(1):79-85. PubMed ID: 3871315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental pulmonary inflammatory injury in the monkey.
    Revak SD; Rice CL; Schraufstätter IU; Halsey WA; Bohl BP; Clancy RM; Cochrane CG
    J Clin Invest; 1985 Sep; 76(3):1182-92. PubMed ID: 2995448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of bronchoalveolar lavage with methylene blue.
    Baughman RP; Bosken CH; Loudon RG; Hurtubise P; Wesseler T
    Am Rev Respir Dis; 1983 Aug; 128(2):266-70. PubMed ID: 6881688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers.
    Vogelmeier C; Kirlath I; Warrington S; Banik N; Ulbrich E; Du Bois RM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):536-41. PubMed ID: 9032191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies.
    el Yamani J; Hayem A; Lafitte JJ; Gressier B; Mizon J
    Bull Eur Physiopathol Respir; 1986; 22(4):359-63. PubMed ID: 3094607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects.
    Jochum M; Pelletier A; Boudier C; Pauli G; Bieth JG
    Am Rev Respir Dis; 1985 Oct; 132(4):913-4. PubMed ID: 3876796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid dynamics during bronchoalveolar lavage.
    Kelly CA; Fenwick JD; Corris PA; Fleetwood A; Hendrick DJ; Walters EH
    Am Rev Respir Dis; 1988 Jul; 138(1):81-4. PubMed ID: 3059869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of bronchoalveolar lavage with methylene blue.
    Tuomanen E; Hill R
    Am Rev Respir Dis; 1984 Jul; 130(1):146-7. PubMed ID: 6742603
    [No Abstract]   [Full Text] [Related]  

  • 12. The antielastase screen of the lower respiratory tract.
    Bieth JG
    Eur J Respir Dis Suppl; 1985; 139():57-61. PubMed ID: 3876235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy about alpha 1-antitrypsin in bronchoalveolar lavage fluids.
    Stockley RA; Burnett D
    Lancet; 1983 Dec; 2(8362):1311. PubMed ID: 6139655
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of reducing agents on proteolytic enzymes and oxidation of alpha 1-proteinase inhibitor.
    Morrison HM; Burnett D; Stockley RA
    Biol Chem Hoppe Seyler; 1986 Mar; 367(3):177-82. PubMed ID: 3518737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.
    Olsen GN; Harris JO; Castle JR; Waldman RH; Karmgard HJ
    J Clin Invest; 1975 Feb; 55(2):427-30. PubMed ID: 1079211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage.
    Delacroix DL; Marchandise FX; Francis C; Sibille Y
    Am Rev Respir Dis; 1985 Oct; 132(4):829-35. PubMed ID: 2413791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproteases are increased in bronchoalveolar lavage in interstitial lung disease.
    Sibille Y; Martinot JB; Staquet P; Delaunois L; Chatelain B; Delacroix DL
    Eur Respir J; 1988 Jun; 1(6):498-504. PubMed ID: 2458961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome.
    Idell S; Kucich U; Fein A; Kueppers F; James HL; Walsh PN; Weinbaum G; Colman RW; Cohen AB
    Am Rev Respir Dis; 1985 Nov; 132(5):1098-105. PubMed ID: 3877483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors.
    Afford SC; Stockley RA; Kramps JA; Dijkman JH; Burnett D
    Anal Biochem; 1985 Nov; 151(1):125-30. PubMed ID: 3853960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteins in bronchoalveolar lavage fluid].
    Hayem A
    Ann Biol Clin (Paris); 1982; 40(3):231-3. PubMed ID: 6753654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.